Clinical Trial Update: 68Ga-DOTATATE Neuroblastoma Imaging Pilot [Phase 2]

View source ↗

Summary

A Phase 2 pilot study is evaluating 68Ga-DOTATATE PET imaging for neuroblastoma, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• 68Ga-DOTATATE (Gallium-68 DOTATATE)

Snippet

Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke | Conditions: Neuroblastoma | Phase 2 | Status: RECRUITING